Laxmi Dental Q1 FY27 Revenue at ₹75 Cr, Up 13.9%; PAT Grows 23.8%
Laxmi Dental reported its highest ever quarterly revenue of ₹75 crores in Q1 FY27, up 13.9% YoY. PAT grew 23.8% to ₹10.3 crores. The company is investing in manufacturing capacity and acquired land for a new facility. A new CEO was appointed for the USA business.
The announcement details strong financial performance with record revenue and profit growth, alongside strategic expansion plans (land acquisition, capacity enhancement) and key management appointments, all of which are significant for the company's future growth and investor confidence.
The company reported record quarterly revenue and strong year-on-year growth in revenue, EBITDA, and PAT. Significant growth was observed across various business segments, and strategic initiatives like land acquisition and new leadership appointments indicate a positive outlook.
Laxmi Dental Limited announced its Q1 FY27 results, reporting the highest ever quarterly revenue of approximately ₹75 crores, a year-on-year growth of 13.9%. The company also witnessed a healthy improvement in profitability, with EBITDA growing by 20.6% to ₹14.4 crores (19.2% margin) and PAT increasing by 23.8% to ₹10.3 crores (13.8% margin).
The dental lab business showed strong performance with a 23.5% YoY revenue growth, driven by a 37.4% increase in international business. The aligner solutions business also recorded robust growth at 28.6% YoY, with Bizdent growing by 27.8% and Vedia by 29.3%. The paediatric dental business, Kids-e-Dental, grew by an impressive 54.4% YoY.
The company plans to invest in new machinery to expand manufacturing capacity in FY27 and has executed a letter of intent to acquire land in Palghar, Maharashtra, for a new owned facility to improve efficiency and scalability, transitioning from its current leased premises.
During the quarter, Laxmi Dental also appointed a new CEO for its USA business with over 32 years of experience in the medical devices and dental industry to strengthen its US market strategy.
The Q1 FY27 earnings conference call was held on August 12, 2026, at 11:00 AM IST. The transcript of this call, discussing the unaudited financial results for the quarter ended June 30, 2026, has been uploaded to the company's website and the stock exchange.
What to do with a filing like this
Laxmi Dental Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Laxmi Dental Limited. Read the original for the full detail.